These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23799469)

  • 1. Pair-bonding through epigenetics.
    Gundersen B
    Nat Neurosci; 2013 Jul; 16(7):779. PubMed ID: 23799469
    [No Abstract]   [Full Text] [Related]  

  • 2. Behaviour: epigenetically bonded.
    Flight MH
    Nat Rev Neurosci; 2013 Jul; 14(7):457. PubMed ID: 23756635
    [No Abstract]   [Full Text] [Related]  

  • 3. Trichostatin A (TSA) facilitates formation of partner preference in male prairie voles (Microtus ochrogaster).
    Duclot F; Wang H; Youssef C; Liu Y; Wang Z; Kabbaj M
    Horm Behav; 2016 May; 81():68-73. PubMed ID: 27074037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epigenetics changes in Parkinson's disease: a novel therapeutic target.
    Yuan TF; Li J; Shan CL
    CNS Neurosci Ther; 2014 Apr; 20(4):299-300. PubMed ID: 24629108
    [No Abstract]   [Full Text] [Related]  

  • 5. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.
    Tashima T; Murata H; Kodama H
    Bioorg Med Chem; 2014 Jul; 22(14):3720-31. PubMed ID: 24864038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzofused hydroxamic acids: useful fragments for the preparation of histone deacetylase inhibitors. Part 2: 7-fluorobenzothiophenes and benzofurans.
    Marastoni E; Bartoli S; Berettoni M; Cipollone A; Ettorre A; Fincham CI; Mauro S; Paris M; Porcelloni M; Bigioni M; Binaschi M; Nardelli F; Parlani M; Maggi CA; Paoli P; Rossi P; Fattori D
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1603-6. PubMed ID: 25746815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suberoylanilide hydroxamic acid (SAHA) as an agent to attenuate Toll-like receptor 4-induced septic shock.
    Chang WJ; Chang YH; Toledo-Pereyra LH
    J Surg Res; 2013 Nov; 185(1):e35-6. PubMed ID: 23073512
    [No Abstract]   [Full Text] [Related]  

  • 8. An efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors.
    Shahidul Islam M; Nurul Islam M; Ashraful Hoque M; Nishino N; Kato T; Kim HJ; Ito A; Yoshida M
    Bioorg Chem; 2015 Apr; 59():145-50. PubMed ID: 25797804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and Biological Evaluation of Novel Hydroxamic Acid Derivatives Containing Purine Moiety as Histone Deacetylase Inhibitors.
    Xu Z; Yang Y; Mai X; Liu B; Xiong Y; Feng L; Liao Y; Zhang Y; Wang H; Ouyang L; Liu S
    Chem Pharm Bull (Tokyo); 2018; 66(4):439-451. PubMed ID: 29607910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors.
    Musso L; Cincinelli R; Zuco V; Zunino F; Nurisso A; Cuendet M; Giannini G; Vesci L; Pisano C; Dallavalle S
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4457-60. PubMed ID: 26376355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
    Pabba C; Gregg BT; Kitchen DB; Chen ZJ; Judkins A
    Bioorg Med Chem Lett; 2011 Jan; 21(1):324-8. PubMed ID: 21109435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Li DQ; Kumar R
    Hepatology; 2013 Mar; 57(3):1287-8. PubMed ID: 22815144
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-membered cyclic hydroxamic acids as HDAC inhibitors.
    Mutule I; Borovika D; Rozenberga E; Romanchikova N; Zalubovskis R; Shestakova I; Trapencieris P
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):216-23. PubMed ID: 24939099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice.
    Colussi C; Berni R; Rosati J; Straino S; Vitale S; Spallotta F; Baruffi S; Bocchi L; Delucchi F; Rossi S; Savi M; Rotili D; Quaini F; Macchi E; Stilli D; Musso E; Mai A; Gaetano C; Capogrossi MC
    Cardiovasc Res; 2010 Jul; 87(1):73-82. PubMed ID: 20164117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors.
    Varasi M; Thaler F; Abate A; Bigogno C; Boggio R; Carenzi G; Cataudella T; Dal Zuffo R; Fulco MC; Rozio MG; Mai A; Dondio G; Minucci S; Mercurio C
    J Med Chem; 2011 Apr; 54(8):3051-64. PubMed ID: 21417419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length.
    Islam NM; Kato T; Nishino N; Kim HJ; Ito A; Yoshida M
    Bioorg Med Chem Lett; 2010 Feb; 20(3):997-9. PubMed ID: 20045316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting chromatin remodelers to treat hepatocellular carcinoma.
    Vinciguerra M
    Hepatology; 2013 Mar; 57(3):1287. PubMed ID: 22745026
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors.
    De Vreese R; D'hooghe M
    Eur J Med Chem; 2017 Jul; 135():174-195. PubMed ID: 28453994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors are unable to synergize with ABT-737 in killing primary chronic lymphocytic leukaemia cells in vitro.
    Ralli R; Banks KM; Wiegmans AP; Carney D; Seymour JF; Johnstone RW; Alsop AE
    Leukemia; 2012 Jun; 26(6):1433-5. PubMed ID: 22289920
    [No Abstract]   [Full Text] [Related]  

  • 20. Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?
    Shen S; Kozikowski AP
    ChemMedChem; 2016 Jan; 11(1):15-21. PubMed ID: 26603496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.